QMS board approves composite scheme of arrangement, BeamOptics acquisition

Listed-company acquisitionDemerger ratio announcedScheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

QMSMEDI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.8%Reaction day

₹199.00

prior close

₹206.47

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+5.3% vs market

On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+3.8-1.6+5.3

Next day

+8.9-0.6+9.5

+3.5-0.8+4.3

-1.7-2.1+0.4

-6.6-2.1-4.5

-2.5-0.8-1.7

-3.5-3.8+0.3

15d

-12.6-6.9-5.7

-11.1-8.0-3.0

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

QMS board approved a composite scheme to demerge its Healthcare Services business (Rs 37.17 Cr, 24.41 percent of FY26 turnover) and HCAH's similar business into wholly owned subsidiary Saarathi Healthcare. Share ratio: 1 Saarathi share per 1 QMS share. Saarathi to seek NSE listing. Also signed merger co-operation and shareholders agreements. Additionally, QMS to acquire 100 percent of BeamOptics Scientific, a Pune-based optics and diagnostics maker with FY26 revenue of Rs 113.81 Lakhs, via Binding MOU, subject to NCLT approval.

Likely market impact

Healthcare arm restructures into a separately listed entity; QMS shareholders get Saarathi shares. BeamOptics adds diagnostics to portfolio. Both subject to NCLT and other approvals.